Recent coverage from the Washington Post illustrates how the media (and even some in the scientific community) have exaggerated the risk COVID-19 poses to the elderly and downplayed the efficacy of vaccination in this age group.
An unexpected delay in the FDA's authorization of COVID shots for children under age 5 could amplify parents' existing concerns about vaccinating their kids. Here's what we know about the situation.
Dozens of studies examining the effects of vaccine mandates have been published over the last year. A pre-print review of this literature has found that requiring COVID-19 vaccination may carry significant costs, including a deepening distrust of public health authorities and greater vaccine hesitancy.
Drs. Robert Popovian (a member of the Scientific Advisory Board at ACSH) and Radife Kiral, both at Pfizer, examine the response of our healthcare system to the COVID pandemic. In some areas we did well; in others not so well. What can we do better in the future?
Several superficially plausible arguments against COVID-19 vaccination continue to pop up across the internet, usually phrased as leading questions. Are they as solid as they seem? A little investigation suggests they are mostly speculation.
Research has shown that adverse events following COVID-19 vaccination are very rare. Another large study of VAERS reports strengthens this conclusion.
The media likes to compare COVID-19 outcomes in different states based on carefully selected metrics. A closer look indicates that these match-ups are less compelling than reporters think. This has consequences for the public's trust in science.
Many tobacco control advocates have attacked vaping by emphasizing the risk it poses to teenagers. While children should never use any nicotine product, there's a strong case to be made that the campaign against teen vaping has distracted us from tackling a critical public health threat: adult smoking.
Some experts have argued that America's expensive, inefficient health care system is to blame for our intense vaccine hesitancy. While this is a plausible explanation, it misses the key problem—the politicization of medicine, along with almost everything else in our culture.
As the Biden Administration's booster shot roll out approaches, we have plenty of evidence that the primary COVID vaccines are still very effective, a growing number of experts say, but very little data to justify widespread use of boosters. This kind of open policy debate is exactly what we need.
Yet another study has found that the authorized COVID-19 vaccines greatly reduce infection. Let's take a look at this latest paper in the context provided by previously published research on vaccine efficacy.
A new clinical trial examining the efficacy of masking on COVID-19 transmission has garnered a lot of media coverage. What the study shows and what people have been told the study shows are very different.